Cerity Partners LLC reduced its stake in Addus HomeCare Co. (NASDAQ:ADUS - Free Report) by 3.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 81,265 shares of the company's stock after selling 3,098 shares during the quarter. Cerity Partners LLC owned about 0.45% of Addus HomeCare worth $10,251,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of ADUS. Envestnet Asset Management Inc. raised its holdings in shares of Addus HomeCare by 9.4% in the fourth quarter. Envestnet Asset Management Inc. now owns 42,698 shares of the company's stock worth $5,352,000 after buying an additional 3,659 shares during the last quarter. Dynamic Technology Lab Private Ltd increased its position in shares of Addus HomeCare by 68.9% in the 4th quarter. Dynamic Technology Lab Private Ltd now owns 3,750 shares of the company's stock valued at $470,000 after acquiring an additional 1,530 shares during the period. Wells Fargo & Company MN raised its stake in Addus HomeCare by 22.2% in the 4th quarter. Wells Fargo & Company MN now owns 31,918 shares of the company's stock worth $4,001,000 after acquiring an additional 5,809 shares during the last quarter. Alliancebernstein L.P. lifted its position in Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after acquiring an additional 91 shares during the period. Finally, Meeder Asset Management Inc. purchased a new stake in Addus HomeCare during the 4th quarter valued at about $77,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on ADUS shares. Stephens restated an "overweight" rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Wednesday, March 12th. Macquarie reissued an "outperform" rating and set a $129.00 price target on shares of Addus HomeCare in a research report on Thursday, February 27th. Oppenheimer upped their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a report on Friday, January 24th. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a research note on Thursday, April 10th. Finally, StockNews.com downgraded shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. One research analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $132.78.
Check Out Our Latest Report on Addus HomeCare
Addus HomeCare Trading Up 0.9 %
NASDAQ ADUS traded up $0.94 on Wednesday, reaching $100.18. 24,717 shares of the company were exchanged, compared to its average volume of 163,448. Addus HomeCare Co. has a fifty-two week low of $87.88 and a fifty-two week high of $136.72. The business's fifty day moving average price is $100.32 and its 200 day moving average price is $117.64. The stock has a market capitalization of $1.82 billion, a P/E ratio of 22.92, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Equities research analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Addus HomeCare Profile
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.